Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidence-Reference-Cited by-同舟云学术

Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidence

Published:2021-02-02 Issue:6 Volume:22 Page:423-433
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Punekar Y S¹^ORCID,Parks D²,Joshi M³,Kaur S⁴,Evitt L¹,Chounta V¹,Radford M¹,Jha D³,Ferrante S²,Sharma S⁴,Van Wyk J¹,de Ruiter A¹⁵

Affiliation:

1. ViiV Healthcare Brentford UK

2. GlaxoSmithKline Collegeville PA USA

3. GlaxoSmithKline Knowledge Centre Gurgaon India

4. Parexel India Chandigarh India

5. Guy’s and St Thomas’ NHS Foundation Trust London UK

Funder

ViiV Healthcare

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13050

Reference53 articles.

1. European AIDS Clinical Society (EACS).European aids clinical society guidelines version 10.0. Available from:https://www.eacsociety.org/files/2019_guidelines‐10.0_final.pdf(accessed 17 July 2020).

2. WHO.The use of antiretroviral drugs for treating and preventing HIV infection. Available from:http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf?sequence=1(accessed December 5 2019).

3. WHO.Updated recommendations on first‐line and second‐line antiretroviral regimens and post‐exposure prophylaxis and recommendations on early infant diagnosis of HIV. Available from:http://apps.who.int/iris/bitstream/handle/10665/273632/WHO‐CDS‐HIV‐18.18‐eng.pdf?ua=1(accessed December 5 2019).

4. Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Available from.https://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL003533.pdf(accessed December 5 2019).

5. HIV Infection and Bone Abnormalities

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-06-01

2. Dolutegravir induces FOLR1 expression during brain organoid development;Frontiers in Molecular Neuroscience;2024-05-17

3. Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana;Viruses;2024-05-01

4. Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care;HIV/AIDS - Research and Palliative Care;2024-04

5. Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV;HIV Medicine;2024-02-20